Go to The Journal of Clinical Investigation
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
  • Physician-Scientist Development
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Immunology
    • Metabolism
    • Nephrology
    • Oncology
    • Pulmonology
    • All ...
  • Videos
  • Collections
    • In-Press Preview
    • Resource and Technical Advances
    • Clinical Research and Public Health
    • Research Letters
    • Editorials
    • Perspectives
    • Physician-Scientist Development
    • Reviews
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • In-Press Preview
  • Resource and Technical Advances
  • Clinical Research and Public Health
  • Research Letters
  • Editorials
  • Perspectives
  • Physician-Scientist Development
  • Reviews
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
Hyperosmotic stimuli activate polycystin proteins to aid in urine concentration
Karla M. Márquez-Nogueras, Ryne M. Knutila, Virdjinija Vuchkovska, Charlie Yang, Patricia Outeda, Darren P. Wallace, Ivana Y. Kuo
Karla M. Márquez-Nogueras, Ryne M. Knutila, Virdjinija Vuchkovska, Charlie Yang, Patricia Outeda, Darren P. Wallace, Ivana Y. Kuo
View: Text | PDF
Research Article Cell biology Nephrology

Hyperosmotic stimuli activate polycystin proteins to aid in urine concentration

  • Text
  • PDF
Abstract

Autosomal dominant polycystic kidney disease (ADPKD) is caused by mutations in PKD1 or PKD2, which encode polycystin-1 (PC1) and polycystin-2 (PC2), respectively. These proteins are thought to form a signaling complex that can flux cations, including calcium. One of the earliest symptoms in ADPKD is a decline in the concentrating ability of the kidneys, occurring prior to cyst formation. We reasoned that hyperosmolality stimulates the polycystin complex, and that the loss of this function impairs water reabsorption. We found that hyperosmolality resulted in the phosphorylation of microtubule-associated protein 4 (MAP4) in a PC1-dependent manner, which then elicited ER-localized PC2 calcium signals. ER-localized PC2 hyperosmotic calcium signals were required for trafficking of the water channel aquaporin (AQP2). Precystic PC1-KO and PC2-KO murine kidneys had cytosol-localized AQP2 and diluted urine compared with their respective controls. Kidney tissue sections from ADPKD patients showed decreased AQP2 apical membrane localization in cystic and noncystic tubules. Our study demonstrates that osmolality is a physiological stimulus of the polycystin complex, and loss of polycystin osmosensing results in impaired water reabsorption via AQP2. This likely contributes to the declined concentrating ability of the kidneys and high circulating vasopressin levels in patients with ADPKD.

Authors

Karla M. Márquez-Nogueras, Ryne M. Knutila, Virdjinija Vuchkovska, Charlie Yang, Patricia Outeda, Darren P. Wallace, Ivana Y. Kuo

×

Figure 4

The PC2 and MAP4 interaction is dependent on MAP4 phosphorylation.

Options: View larger image (or click on image) Download as PowerPoint
The PC2 and MAP4 interaction is dependent on MAP4 phosphorylation.
(A) F...
(A) Function of MAP4 in microtubule stability. (B) Expression of p-MAP4 in C2C12 CTL and PC2-KO cells at 300 mOsm and 400 mOsm. Total protein was used as loading control. (C) p-MAP4 increased in C2C12 CTL cells after hyperosmotic stimuli. p-MAP4 levels in PC2-KO cells did not change with osmotic shifts. Similar results seen in IMCD3 cells (data not shown). Statistical analysis by Kruskal-Wallis test followed by Dunn’s test. (D) Diagram of PC2-MAP4 interaction with the phospho-null and phospho-mimetic mutants. (E) Immunoprecipitation assay from IMCD3 PC2-KO cells expressing PC2-mCherry and MAP4-eGFP, MAP4S696A-eGFP, or MAP4S696D-eGFP. PC2-MAP4 interaction was stabilized with the expression of MAP4S696A-eGFP. IN, input; FT, flow-through; E, elution. (F) Representative images of C2C12 PC2-KO cells cotransfected with MAP4-eGFP, PC2-mCherry (top left panel), or MAP4S696A-eGFP (bottom left panel). Colocalization between PC2-mCherry and MAP4-eGFP decreased after hyperosmotic stimuli (middle panels) but unchanged with MAP4S696A. Scale bars: 2 μm. (G) Quantification of ER-mCherry and MAP4-eGFP (ER), PC2-mCherry and MAP4-eGFP (MAP4), PC2-mCherry and MAP4S696A-eGFP (S696A), and PC2-mCherry and MAP4S696D-eGFP (S696D) at 300 mOsm (black bars) and after hyperosmotic stimuli (400 mOsm, blue bars). Statistical analysis was by Mann-Whitney U test. In C and G, each dot is an independent biological replicate (n = 3–4). Bar graphs represent mean ± SEM. P values listed in each panel.

Copyright © 2026 American Society for Clinical Investigation
ISSN 2379-3708

Sign up for email alerts